Unpublished research shows avoiding the extremes is a common approach marketers need to address
Data back to 1870 show similarities in the worst banking system shocks — focusing on loose lending before a meltdown
Researchers aim to help the agency, drug companies and patients better understand the complex authorization process
Private equity investors weigh the total cost of capital — not just debt, but equity as well — when pursuing buyouts
Other safety measures are easier to implement, but research suggests how female driver pool could be increased
The relationship between short- and longer-term moving averages has strong predictive power for share price returns
In certain competitive situations, cost transparency can provide an edge
Collective action, rather than each brand working alone, appears more effective and costs less
The rise of passive investing leaves companies mistrusting market signals on how best to deploy capital
Seeking to improve school attendance, researchers learn how some students think
A study looks at how changes in FDA labeling affect pediatric utilization of drugs
The same message that works with U.S. households is effective in the developing world
Research shows that people have a sincere desire to see projects take flight
Stuart Gabriel’s research shows how a vibrant economic hub loses essential residents
The Fed’s gambit didn’t trigger a home-price recovery, but research shows it reduced subprime foreclosure risk
Valentin Haddad’s research finds that insurers’ patient investing shields risky assets — and those who hold them — from steeper declines